Research

An Unexpected Threat to HPV

A nutritional supplement derived from mushrooms shows promise in treating the incurable cancer-causing virus


Judith A. Smith_UTHealth_007-RE
By Shea Connelly | December 3, 2014

Human papillomavirus, or HPV, is the most common sexually transmitted infection in the United States, affecting between 60 and 80 percent of sexually active adults. Despite its prevalence, there is no cure. A study at The University of Texas Health Science Center (UTHealth) Medical School at Houston, however, could provide hope for people with HPV. It comes in the form of a pill containing an extract derived from an unusual source: mushrooms.

The extract, Active Hexose Correlated Compound (AHCC), comes from shiitake mushrooms and is a readily available nutritional supplement. It has been used to relieve side effects of chemotherapy, which is what originally interested Judith A. Smith, Pharm.D., associate professor in the Department of Obstetrics, Gynecology and Reproductive Sciences at UTHealth Medical School. Smith began studying AHCC a decade ago.

“From a pharmacology perspective, I wanted to rule out any potential drug interactions with chemotherapy,” said Smith. “We then observed some antitumor effects and started digging deeper and learning more about its immune modulating effects.”

Smith and her team spent two years completing in vitro studies showing the effects of AHCC on HPV, largely because they were so taken aback by the results.

“We had a lot of healthy skeptics, and I’ve probably been the biggest of those skeptics. How could this nutritional supplement possibly eradicate one of the most difficult viruses we’ve been challenged with in the cancer arena?” said Smith.

There is no known cure for HPV, and strains of the virus also cause cancer, including cervical cancer, the second most common in women. Without a cure, women infected with HPV are left to wait and see if they develop cancer.

“If they’re tested and we tell them they’re positive, right now there’s nothing we can do. We say, ‘We’ll check you in another year,’” said Smith. “When HPV testing became approved and recommended, I thought, ‘Wow, how frustrating for women.’ It creates a lot of anxiety and feelings of lack of control.”

“We had a lot of healthy skeptics, and I’ve probably been the biggest of those skeptics. How could this nutritional supplement eradicate one of the most difficult viruses we’ve been challenged with in the cancer arena?” — Judith A. Smith, Pharm. D., associate professor in the Department of Obstetrics, Gynecology and Reproductive Sciences at The University of Texas Health Science Center (UTHealth) Medical School at Houston

Vaccines against HPV are available, but the low vaccination rate and the number of people beyond the age of vaccination mean vast numbers of women are infected and left in limbo.

The lack of options inspired Smith to begin researching HPV a decade ago. Despite the success of the in vitro studies, however, she and her team were not convinced of the possible positive effects of AHCC on HPV.

“We did mouse studies and, again, repeated the mouse studies in two models,” said Smith. “We were able to treat with AHCC and eradicate the HPV, then stop treatment and see a durable response.”

That response was key to determining whether AHCC could be truly effective in treating HPV—it wouldn’t just suppress the virus, but eradicate it. Data from a third animal study enabled Smith and her team to tackle the next hurdle: testing the efficacy of AHCC in human patients. Thanks to philanthropic funds, they were able to complete a pilot study treating ten women with the nutritional supplement.

Each of the women in the pilot study was over 30 and had HPV positive persistent infections, meaning they had been infected for 18 months or more. None of the women had cancerous lesions. A main objective of the pilot study was to determine dosage and length of treatment.

Three patients showed complete eradication after stopping AHCC. Two have yet to complete their courses of AHCC, but have tested HPV negative. The remaining patients stopped taking AHCC before testing completely negative. The next step would be a Phase II double-blinded, placebo-controlled trial to confirm the early results of the pilot study.

The regimen they determined involves taking three grams of AHCC on an empty stomach once a day for up to five months. It’s a course of treatment Smith gladly shares.

“It’s definitely in the category of ‘it won’t hurt you,’” said Smith. “Will it definitely help you? I can’t tell you that. I’m not in any position, nor do we have the data, to say yes. We’re not there yet, but we’re trying to get there.”

The success of AHCC so far has been a happy surprise. “We had been looking at this the whole time going, ‘If this works, the potential is huge,’” said Smith. “And now ten years later, the potential could be more than I envisioned.”

Should AHCC studies continue to bring positive results, Smith’s vision is to make the treatment available to as many women as possible, eliminating that limbo between HPV infection and possible cancer diagnosis.

“If further studies confirm our early findings, my ultimate goal would be to be able to find the financial means to support bringing this to underserved patients throughout the world, and here in Texas. That’s where the HPV virus in women with no access to health care is kind of a perfect storm as to why people end up with cancer,” said Smith. “I really want to help those patients.”




Social Posts

profile_image

Veterans Affairs

@DeptVetAffairs

California: Ripon’s military heroes from past wars honored with six-foot-long photo banners https://t.co/SZ3bbyvqcH via @mantecabulletin

38 mins ago
profile_image

BCMHouston

@bcmhouston

RT @BCMHouston_News: Did you see @BCMFromtheLabs's Image of the Month? Learn more about assembling a rotavirus factory here: https://t.co/d…

50 mins ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

RT @MDAndersonTrial: A Phase II Study of INVAC-1 Treatment of Patients with High-Risk Chronic Lymphocytic Leukemia now Enrolling https://t.…

57 mins ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

DYK our Outreach Physics team monitors 98% of #radiationtherapy facilities in the U.S. to ensure patients are receiving the correct dosage?Learn more about our specialized team: https://t.co/lZMlUxnvOf #endcancer

1 hour ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

@tarablue77 @Saints @drewbrees @SeanPayton @camjordan94 @Cantguardmike @BenjaminSWatson @T_Hill4 @A_kamara6 @thomasmorstead @AlexAnzalone47 @MarkIngram22 @shonrp2 @wil_lutz5 Let us know if you need anything while you're here, Tara. We're sending good vibes your way.

1 hour ago
profile_image

Veterans Affairs

@DeptVetAffairs

The Point-in-Time Count is one of the ways VA estimates the homeless Veteran population in the U.S. Thank you to all the volunteers who are participating in the count across America. Read about the count and last year’s results: https://t.co/omTnfYz9xQ #EndVeteranHomelessness https://t.co/gwvwRCFMHI

2 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

Vietnam Veteran receives replacement medals https://t.co/aMTfLrP5WS via @theindependent

3 hours ago
profile_image

UTHealth

@UTHealth

RT @UTPhysicians: UTHealthCares, a student-led initiative to help the community, is holding their 2nd annual health fair on Saturday, Jan.…

3 hours ago
profile_image

UTHealth

@UTHealth

RT @UTPhysicians: A well-woman exam is an important way to stay healthy. The main goals are to document/update your health habits and histo…

3 hours ago
profile_image

UTHealth

@UTHealth

RT @UTPhysicians: Falling can lead to broken bones or disability, and each year 1 in 4 older adults are injured due to falls. To help lower…

3 hours ago
profile_image

Houston Methodist

@MethodistHosp

We were honored to host The Rev. Dr. Derek. Barber King, Sr., nephew of Dr. Martin Luther King, Jr., to celebrate the life & legacy of Dr. King.Dr. King’s unwavering focus & passion will forever be an inspiration on our path forward. #MLKDay https://t.co/HimY0WY4fP

16 hours ago
profile_image

Memorial Hermann

@memorialhermann

According to the American Cancer Society, obesity acts as a risk factor in developing liver, pancreatic and endometrial cancers. Here are simple exercises to sit less and move more: https://t.co/XtYhfqN2RV.

17 hours ago
profile_image

Texas Children's

@TexasChildrens

Join us for a twitter chat on Jan. 23 at 2 p.m. CST (3 p.m. ET) to discuss what you can do to have a healthy baby. #Best4YouBest4Baby #WellnessWed https://t.co/CGMqI4SmMK

17 hours ago
profile_image

CHI St. Luke's Health

@CHI_StLukes

.@tdouglaslawson, President of Baylor St. Luke's Medical Center & CEO of the CHI Texas Division, led a moving ceremony with Minister Howard Watson and Reverend D. Darnell to celebrate the vital work and lasting national impact of Dr. King. https://t.co/3hAiyGJzww

18 hours ago
profile_image

CHI St. Luke's Health

@CHI_StLukes

Facilities across the CHI Texas Division are honoring the life and legacy of Dr. Martin Luther King, Jr. today. We are proud to be an organization committed to social justice, diversity, and respect for pioneers in equality like Dr. King. #MLKday

18 hours ago